Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study

Detalhes bibliográficos
Autor(a) principal: Rezende, Tatiana M. N.
Data de Publicação: 2017
Outros Autores: Maia-de-Oliveira, Joao Paulo, Kandratavicius, Ludmyla, Machado-de-Sousa, Joao Paulo, Abrao, Joao, Prado, Daniel Almeida, Bressan, Rodrigo A. [UNIFESP], Lacerda, Acioly L. T. [UNIFESP], Zuardi, Antonio W., Baker, Glen B., Dursun, Serdar M., Hallak, Jaime E. C.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/0101-60830000000141
https://repositorio.unifesp.br/handle/11600/58201
Resumo: Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.
id UFSP_4822a28324d66f5cf6cb25d09a58aa0c
oai_identifier_str oai:repositorio.unifesp.br/:11600/58201
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind studyNitric oxidesodium nitroprussideketamineschizophreniapsychosisBackground: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Neurosci & Behav, Ribeirao Preto, SP, BrazilNatl Inst Sci & Technol Translat Med INCT TM, Fortaleza, Ceara, BrazilUniv Fed Rio Grande do Norte, Dept Clin Med, Natal, RN, BrazilFed Univ Sao Paulo Unifesp, Dept Psychiat, Sao Paulo, SP, BrazilUniv Alberta, Dept Psychiat, Neurochem Res Unit, Edmonton, AB, CanadaFed Univ Sao Paulo Unifesp, Dept Psychiat, Sao Paulo, SP, BrazilWeb of ScienceUniv Sao Paulo, Inst Psiquiatria2020-09-01T13:21:19Z2020-09-01T13:21:19Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion149-153application/pdfhttp://dx.doi.org/10.1590/0101-60830000000141Archives Of Clinical Psychiatry. Sao Paulo, v. 44, n. 6, p. 149-153, 2017.10.1590/0101-60830000000141S0101-60832017000600149.pdf0101-6083S0101-60832017000600149https://repositorio.unifesp.br/handle/11600/58201WOS:000419784600003engArchives Of Clinical PsychiatrySao Pauloinfo:eu-repo/semantics/openAccessRezende, Tatiana M. N.Maia-de-Oliveira, Joao PauloKandratavicius, LudmylaMachado-de-Sousa, Joao PauloAbrao, JoaoPrado, Daniel AlmeidaBressan, Rodrigo A. [UNIFESP]Lacerda, Acioly L. T. [UNIFESP]Zuardi, Antonio W.Baker, Glen B.Dursun, Serdar M.Hallak, Jaime E. C.reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-01T22:57:41Zoai:repositorio.unifesp.br/:11600/58201Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-01T22:57:41Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
title Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
spellingShingle Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
Rezende, Tatiana M. N.
Nitric oxide
sodium nitroprusside
ketamine
schizophrenia
psychosis
title_short Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
title_full Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
title_fullStr Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
title_full_unstemmed Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
title_sort Effects of sodium nitroprusside in the prevention of schizophrenia-like symptoms induced by ketamine - A translational double-blind study
author Rezende, Tatiana M. N.
author_facet Rezende, Tatiana M. N.
Maia-de-Oliveira, Joao Paulo
Kandratavicius, Ludmyla
Machado-de-Sousa, Joao Paulo
Abrao, Joao
Prado, Daniel Almeida
Bressan, Rodrigo A. [UNIFESP]
Lacerda, Acioly L. T. [UNIFESP]
Zuardi, Antonio W.
Baker, Glen B.
Dursun, Serdar M.
Hallak, Jaime E. C.
author_role author
author2 Maia-de-Oliveira, Joao Paulo
Kandratavicius, Ludmyla
Machado-de-Sousa, Joao Paulo
Abrao, Joao
Prado, Daniel Almeida
Bressan, Rodrigo A. [UNIFESP]
Lacerda, Acioly L. T. [UNIFESP]
Zuardi, Antonio W.
Baker, Glen B.
Dursun, Serdar M.
Hallak, Jaime E. C.
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rezende, Tatiana M. N.
Maia-de-Oliveira, Joao Paulo
Kandratavicius, Ludmyla
Machado-de-Sousa, Joao Paulo
Abrao, Joao
Prado, Daniel Almeida
Bressan, Rodrigo A. [UNIFESP]
Lacerda, Acioly L. T. [UNIFESP]
Zuardi, Antonio W.
Baker, Glen B.
Dursun, Serdar M.
Hallak, Jaime E. C.
dc.subject.por.fl_str_mv Nitric oxide
sodium nitroprusside
ketamine
schizophrenia
psychosis
topic Nitric oxide
sodium nitroprusside
ketamine
schizophrenia
psychosis
description Background: Recent evidence has shown improvements in schizophrenia symptoms after the infusion of sodium nitroprusside (SNP), a nitric oxide (NO) donor. In the rat model of schizophrenia using ketamine injection, pretreatment with SNP seems to prevent behavioral changes associated with positive symptoms for up to one week. Objective: We investigated whether SNP would have preventative effects on psychogenic symptoms induced by ketamine in healthy subjects. Methods: Healthy subjects (N = 38) were assigned to distinct groups that received SNP in different doses (0.15, 0.25, and 0.5 mcg/kg/min). First, participants received an infusion of SNP or placebo over 75 minutes. After 10 minutes, they were injected for 1 minute with a bolus of 0.26 mg/kg of ketamine and a maintenance dose was started 5 minutes later, with 0.25 mg/kg/h of ketamine for 50 minutes. Results: Ketamine-induced psychopathological alterations induced were reduced by SNP, as assessed with the Brief Psychological Rating Scale. Scores in the objective subscale of the Clinician-Administered Dissociative States Scale were also lower in SNP sessions compared to placebo. SNP had protective effects against deterioration in facial emotion and identity recognition tasks induced by ketamine. Discussion: Our findings support the view that SNP has preventative properties against psychotic manifestations.
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-09-01T13:21:19Z
2020-09-01T13:21:19Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/0101-60830000000141
Archives Of Clinical Psychiatry. Sao Paulo, v. 44, n. 6, p. 149-153, 2017.
10.1590/0101-60830000000141
S0101-60832017000600149.pdf
0101-6083
S0101-60832017000600149
https://repositorio.unifesp.br/handle/11600/58201
WOS:000419784600003
url http://dx.doi.org/10.1590/0101-60830000000141
https://repositorio.unifesp.br/handle/11600/58201
identifier_str_mv Archives Of Clinical Psychiatry. Sao Paulo, v. 44, n. 6, p. 149-153, 2017.
10.1590/0101-60830000000141
S0101-60832017000600149.pdf
0101-6083
S0101-60832017000600149
WOS:000419784600003
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Archives Of Clinical Psychiatry
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 149-153
application/pdf
dc.coverage.none.fl_str_mv Sao Paulo
dc.publisher.none.fl_str_mv Univ Sao Paulo, Inst Psiquiatria
publisher.none.fl_str_mv Univ Sao Paulo, Inst Psiquiatria
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268451351429120